Tackling the challenges of clinical trials in palliative care

Pharmaceutical Medicine

Volumn 25, Issue 1, 2011, Pages 7-15

  Currow, David C ^a   Agar, Meera R ^a,b   Abernethy, Amy P ^a,c  

^a FLINDERS UNIVERSITY   (Australia)

^b Braeside Hospital   (Australia)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Clinical trial design; Data collection; Ethics; Palliative care; Quality of life; Research and development

Indexed keywords

ADVERSE OUTCOME; CLINICAL PRACTICE; CLINICAL RESEARCH; CONTROLLED CLINICAL TRIAL (TOPIC); ETHICS; HEALTH CARE QUALITY; HUMAN; INFORMATION PROCESSING; PALLIATIVE THERAPY; PATIENT REFERRAL; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

EID: 79751511081     PISSN: 11782595     EISSN: 11791993     Source Type: Journal    
DOI: 10.2165/11539790-000000000-00000     Document Type: Review

References (42)

1. WHO. Health statistics and health information systems [online]. Available from URL: http://www.who.int/healthinfo/morttables/en/index.html [Accessed 2010 Jun 29]
2. Clark D. Palliative care history: a ritual process? Eur J Cancer Care 2000; 7 (2): 50-4
3. Clark D. Palliative care history: a ritual process? Eur J Cancer Care 2000; 7 (2): 50-4 (Pubitemid 46621771)
4. Doyle D. Palliativemedicine: thefirst 18 yearsofanewsubspecialityofgeneral medicine. J R Coll Physicians Edinb 2005; 35: 199-205
5. Lunney JR, Lynn J, Foley DJ, et al. Patterns of functional decline at the end of life. JAMA 2003; 289: 2387-92 (Pubitemid 37430171)
6. Gill TM, Gahbauer EA, Han L, et al. Trajectories ofdisability in the last year of life. N Engl J Med 2010; 362 (13): 1173-80
7. Solano J, Gomes B, Higginson I. A comparison ofsymptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 2006; 31: 58-69 (Pubitemid 43143299)
8. Currow DC Why don't we do more rigorous clinical research so that we can stop experimenting on patients? J Pall Med 2010; 13 (6): 636-7
9. Currow DC, To THM, Abernethy AP. Prescribing at times of clinical transition in chronic or progressive diseases. Int J Gerontology 2009; 3 (1): 1-8
10. Masso M, Dodds S, Fildes D, et al. Ethical research in palliative care: a guide through the Human Research Ethics Committee process. Canberra (ACT), Commonwealth of Australia Department of Health and Ageing, 2004
11. White C, Gilshenan K, Hardy J. A survey of the views of palliative care healthcare professionals towards referring cancer patients to participate in randomized controlled trials in palliative care. Support Care Cancer 2008 Dec; 16 (12): 1397-405
12. White C, Hardy J. What do palliative care patients and their relatives think about research in palliative care? A systematic review. Support Care Cancer 2010; 18 (8) 905-11
13. Steinhauser KE, Christakis NA, Clipp EC, et al. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA 2000 Nov 15; 284 (19): 2476-82
14. Duke S, Bennett H. A narrative review of the published ethical debates in palliative care research and an assessment of their adequacy to inform re-search governance. Palliat Med 2010; 24 (2): 111-26
15. Carter R. Cicely Saunders: founder of the Hospice Movement. Selected letters 1959-1999 [book review]. J R Soc Med 2003 Mar; 96 (3): 149-51
16. Tieman J, Sladek R, Currow DC Changes in the quantity and level ofevidence ofpalliative and hospice care literature: the last century. J Clin Oncol 2008; 26 (35): 5679-83
17. Mc Whinney IR, Bass MJ, Donner A. Evaluation of a palliative care service: problems and pitfalls. Br Med J 1994 Nov 19; 309 (6965): 1340-2 (Pubitemid 24345974)
18. Aoun SM, Kristjanson LJ. Challenging the framework for evidence in palliative care research. Palliat Med 2005 Sep; 19 (6): 461-5 (Pubitemid 41430819)
19. National Health and Medical Research Council. National statement on ethical conduct in human research [online]. Available from URL: http://www. nhmrc.gov.au/publications/ethics/2007-humans/contents.htm [Accessed 2010 Jun 29]
20. ICH. International Conference on Harmonisation WHO good clinical practice standards [online]. Available from URL: http://www.ich.org/products/guidelines/ efficacy/article/efficacy-guidelines.html [Accessed 2010 Jun 29]
21. Le Blanc TW, Wheeler JL, Abernethy AP. Research in end-of-life settings: an ethical inquiry. J Pain Palliat Care Pharmacother 2010; 24 (3): 244-50
22. Clark K, Currow DC, Agar M, et al. A pilot phase II randomized, cross-over, double-blinded, controlled efficacy study of octreotide versus hyoscine hy-drobromide for control of noisy breathing at the end-of-life. J Pain Palliat Care Pharmacother 2008; 22 (2): 131-8
23. Bach JR. Palliative care becomes 'uninformed euthanasia' when patients are not offered non-invasive life preserving options. J Palliat Care 2007 Autumn; 23 (3): 181-4
24. Keeley PW. Improving the evidence base in palliative medicine: a moral imperative. J Med Ethics 2008; 34 (10): 757-60
25. Pavis H, Wilcock A. Prescribing ofdrugs for use outside their licence in palliativecare: surveyofspecialistsintheUnited Kingdom. BMJ2001 Sep 1; 323 (7311): 484-5 (Pubitemid 32822286)
26. Bredin M. Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. Br Med J 1999; 31 (7188): 901-4 (Pubitemid 29191924)
27. Abernethy AP, Mc Donald CF, Frith PA, et al. Effect of palliative oxygen versus medical (room) air in relieving breathlessness in patients with refrac-tory dyspnea: a double-blind randomized controlled trial (NCT00327873). Lancet 2010; 376 (9743): 784-93
28. Corner J. Is there a research paradigm for palliative care? Palliat Med 1996; 10 (3): 201-8 (Pubitemid 26234128)
29. Rinck GC, van den Bos GA, Kleijnen J, et al. Methodologic issues in effectiveness research on palliative cancer care: a systematic review. J Clin Oncol 1997; 15 (4): 1697-707 (Pubitemid 27167411)
30. Currow DC, Wheeler J, Glare P, et al. A framework for generalizability in palliative care. J Pain Symptom Manage 2009; 37: 373-86
31. Palmer J. Analysis ofmissing data in palliative care studies. J Pain Symptom Manage 2004; 286: 612-8 (Pubitemid 39626107)
32. Fielding S. Methods for handing missing data in palliative care. Palliat Med 2006; 20: 791-8 (Pubitemid 46040130)
33. Currow DC, Shelby-James TM, Agar M, et al. Planning phase III multi-site clinical trials in palliative care: the role ofconsecutive cohort audits to identify potential participant populations. Support Care Cancer 2010; 18 (12) 1571-9
34. Abernethy AP, Clark K, Currow DC How should we conduct and interpret phase III clinical trials in palliative care? J Pain Symptom Manage 2010; 39 (1): E6-8
35. Hardy J, Shelby-James T, Currow DC Research in palliative care: is death always an adverse event? Intern Med J 2010 Jan; 40 (1): 89-90
36. Abernethy AP, Currow DC, Wurzelmann J, et al. Enhancing enrollment in palliative care trials: key insights from a randomized, placebo-controlled study. J Support Oncol 2010; 8 (3): 139-44
37. Rowett D, Ravenscroft PJ, Hardy J, et al. Using national health policies to improve access to palliative care medications in the community. J Pain Symptom Manage 2009; 37 (3): 395-402
38. CONSORT. The CONSORT Statement [online]. Available from URL: http://www.consort-statement.org/consort-statement [Accessed 2010 Oct 7]
39. Whalen GF, Kutner J, Byock I, et al. Implementing palliative care studies. J Pain Symptom Manage 2007; 34 (1 Suppl.): S40-S8
40. Mc Caffrey N, Eckermann S, Currow DC Measuring impacts of value to patients is crucial when evaluating palliative care. J Pain Symptom Manage 2009; 37 (6): 7-9
41. Currow DC, Agar M, Tieman J, et al. Multisite research allows adequately powered palliative care trials: web-based data management makes it achiev-able today. Pall Med 2008; 22 (1): 91-2 (Pubitemid 351351376)
42. Nikles J, Mitchell G, Walters J, et al. Prioritising drugs for single patient (n-of-1) trials in palliative care. Palliat Med 2009; 23 (7): 623-34